A Bioequivalence Study of Two Nicotine Lozenges in Fasting Conditions in Healthy Smokers
Status:
Completed
Trial end date:
2019-03-24
Target enrollment:
Participant gender:
Summary
This study will assess the bioequivalence of the test product (Nicotine Prototype Mini
lozenge 2 milligrams [mg]) to a commercial reference product (nicotine polacrilex mini
lozenge 2 mg) in healthy smokers under fasting conditions.